Free Account Opening + AMC Free Demat
Loading...
September 30, 2016 - October 5, 2016

Sakar Healthcare NSE SME IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Sakar Healthcare NSE SME IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 1 0
% 0.00 0.00 0.00 100.00 0.00

Sakar Healthcare NSE SME IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Dilip Davda Avoid

Sakar Healthcare NSE SME IPO Review by Dilip Davda (Avoid)

[Dilip Davda]  Considering hire pricing, only cash surplus risk savvy investors may consider it for long term, others may ignore. Read detail review...

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.